#Ireland #Dublin #Healthcare Conference #Keenova Therapeutics

Keenova Therapeutics to Present at Jefferies Global Healthcare Conference

Keenova Therapeutics plc, an innovative leader in the development and production of therapeutic solutions, has recently announced their participation in the upcoming Jefferies Global Healthcare Conference set to take place in London. This highly anticipated event is scheduled for Wednesday, November 19, 2025, at 10:00 AM GMT (5:00 AM ET).

About the Event

The Jefferies Global Healthcare Conference serves as a premier platform for companies to present their latest innovations and advancements in healthcare. Keenova's management is expected to offer insights into their ongoing projects and advancements in therapeutic areas that address significant unmet medical needs. Attendees can access the live presentation and an archived version through the Investor Relations section of Keenova's official website at www.keenova.com.

Keenova's Mission and Vision

Headquartered in Dublin, Ireland, Keenova Therapeutics focuses on developing branded solutions for patients suffering from rare or neglected conditions. Their diverse portfolio of products spans numerous therapeutic areas, including endocrinology, gastroenterology, hepatology, immunology, neonatal respiratory critical care, and more. By targeting these areas, Keenova aims to improve the quality of life for patients and ensure they live happier and healthier lives.

The company’s robust U.S. manufacturing capabilities ensure they can efficiently deliver their innovative therapeutics. With facilities located in several states including Louisiana, New Jersey, New York, Pennsylvania, and Wisconsin, Keenova is well-positioned to meet both demand and regulation standards needed in today's healthcare environment.

Strategic Importance of Participation

Participation in events like the Jefferies Conference not only elevates Keenova’s profile within the healthcare community but also provides a platform for establishing strategic partnerships and connections with investors and healthcare leaders. This engagement is crucial as Keenova continues to expand its influence and effectiveness in the pharmaceutical sector, particularly in regions with substantial unmet health needs.

Moreover, using their website as a communication tool, Keenova keeps investors informed about press releases, financial updates, and significant company decisions, promoting transparency and timely dissemination of information.

Looking Ahead

As Keenova prepares for its presentation, stakeholders and interested parties eagerly anticipate the insights and advancements that will be shared. The company continues to strive towards its goal of being a pivotal player in transforming treatments for underaddressed conditions, offering hope and improved health outcomes for patients around the globe.

Stay connected with Keenova through their Investor Relations page to receive the latest updates and notifications regarding future developments and presentations.

Conclusion

In summary, Keenova Therapeutics is set to make a significant impact at the Jefferies Global Healthcare Conference in London. Their commitment to addressing unmet medical needs drives their innovation and dedication to patient health, making them a noteworthy entity in the evolving landscape of healthcare.